March 15, 2024 07:00 AM EDTUpdated 03:10 PM

Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Biogen chief medical officer Maha Radhakrishnan is out after four years “as of March 1,” a spokesperson tells Peer Review. Biogen didn’t draw up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Bio­gen los­es CMO, neu­ro­mus­cu­lar leader; John Hood adds pres­i­dent, CFO at En­deav­or Bio­Med­i­cines

Copy Chief

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines